摘要:
Compounds of the general formula (1) or pharmacologically acceptable salts thereof, exhibiting thrombopoietin-like activities: wherein E is methylidyne or nitrilo; R1 is optionally substituted aryl or optionally substituted heteroaryl; R2 is hydrogen or alkyl; W1 is an amino acid residue; A is carbonyl or sulfonyl; X1 is optionally substituted alkylene or optionally substituted alkenylene; and p is 0 or 1.
摘要:
The present invention provides compounds represented by formula (1) below and pharmacologically acceptable salts thereof: wherein R 1 , R 2 , R 3 , and R 4 are as defined in the claims.
摘要:
Chondrongenesis promotors characterized by containing as the active ingredient compounds represented by general formula (I) or salts thereof, wherein R1 is halogeno, lower alkyl, lower alkoxy, or the like; R2 is hydrogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkoxy, acyl, aryl, a heterocyclic group, or the like; R3 is lower alkyl, cycloalkyl, aryl, a heterocyclic group, or the like; R4 is hydrogen, lower alkyl, aryl, a heterocyclic group, or the like; X and Y are each -CH¿2?-, -NH-, or -O-; and n is an integer of 0 to 4.